We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Next-Generation Sequencing Kits Provide Directional Library Generation with Ribosomal RNA Removal

By LabMedica International staff writers
Posted on 21 Nov 2012
New sequencing technology has been developed for end-to-end preparation of RNA sequence libraries in only one day. More...


Cambio (Cambridge, UK), the distributors of Epicentre products in the United Kingdom and Ireland, have added a new range of products to their portfolio. The ScriptSeq Complete kits combine Epicentre’s Ribo-Zero technology and rapid ScriptSeq v2 procedure for end-to-end prep of RNA sequence libraries in just one day.

The kits enable life scientists to rapidly generate directional, paired-end RNA-Seq libraries, usually containing less than 3% rRNA reads, from as small as 100 ng total RNA. 48 ScriptSeq Index PCR primers are available separately for preparing barcoded libraries. ScriptSeq Complete kits are currently available for mouse, human, and rat samples; however, Complete kits for plants and bacteria are expected in early 2013.

ScriptSeq Complete kits remove the need to buy separate kits for the different steps of RNA-Seq library generation, thereby reducing the risk of possible sample loss, bottlenecks, and unexpected costs. The Complete kits have been designed for a rapid, simple workflow, and are less costly than purchasing the components separately.

Related Links:

Cambio



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.